These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8603429

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.
    Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y.
    J Immunol; 1998 Jun 01; 160(11):5554-62. PubMed ID: 9605160
    [Abstract] [Full Text] [Related]

  • 3. Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells.
    Warren DJ, Moore MA.
    J Immunol; 1988 Jan 01; 140(1):94-9. PubMed ID: 3257232
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-10 inhibits cytokine generation from mast cells.
    Arock M, Zuany-Amorim C, Singer M, Benhamou M, Pretolani M.
    Eur J Immunol; 1996 Jan 01; 26(1):166-70. PubMed ID: 8566061
    [Abstract] [Full Text] [Related]

  • 5. IL-4 renders mast cells functionally responsive to endothelin-1.
    Egger D, Geuenich S, Denzlinger C, Schmitt E, Mailhammer R, Ehrenreich H, Dörmer P, Hültner L.
    J Immunol; 1995 Feb 15; 154(4):1830-7. PubMed ID: 7530742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Humoral regulation of eosinophilopoiesis by interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-5].
    Sonoda Y.
    Nihon Rinsho; 1993 Mar 15; 51(3):565-70. PubMed ID: 8492428
    [Abstract] [Full Text] [Related]

  • 8. Stem cell factor can stimulate the formation of eosinophils by two types of murine eosinophil progenitor cells.
    Metcalf D, Mifsud S, Di Rago L.
    Stem Cells; 2002 Mar 15; 20(5):460-9. PubMed ID: 12351816
    [Abstract] [Full Text] [Related]

  • 9. Proliferation and functional responses of bone marrow-derived mast cells after activation.
    Levi-Schaffer F, Shalit M.
    Cell Immunol; 1993 May 15; 148(2):435-43. PubMed ID: 8495499
    [Abstract] [Full Text] [Related]

  • 10. Recombinant murine (rm) interleukin (IL)-5 enhances the eosinophil peroxidase content in cells cultured in vitro compared with rmIL-3 and granulocyte-macrophage colony-stimulating factor.
    Oskéritzian C, Le Mao J, David B.
    Exp Hematol; 1998 Jun 15; 26(6):472-7. PubMed ID: 9620280
    [Abstract] [Full Text] [Related]

  • 11. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
    Benhamou M, Ninio E, Salem P, Hieblot C, Bessou G, Pitton C, Liu FT, Mencia-Huerta JM.
    J Immunol; 1986 Feb 15; 136(4):1385-92. PubMed ID: 2935578
    [Abstract] [Full Text] [Related]

  • 12. Characterization of mast cell precursors by physical means: dissociation from T cells and T cell precursors.
    Yung YP, Wang SY, Moore MA.
    J Immunol; 1983 Jun 15; 130(6):2843-8. PubMed ID: 6602184
    [Abstract] [Full Text] [Related]

  • 13. Short-term and long-term cytokine release by mouse bone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefeldin A.
    Zhu FG, Gomi K, Marshall JS.
    J Immunol; 1998 Sep 01; 161(5):2541-51. PubMed ID: 9725254
    [Abstract] [Full Text] [Related]

  • 14. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar 01; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

  • 15. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M.
    Immunol Lett; 2008 Jun 15; 118(1):88-95. PubMed ID: 18440651
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the growth rate of mouse fibroblasts by IL-3-activated mouse bone marrow-derived mast cells.
    Dayton ET, Caulfield JP, Hein A, Austen KF, Stevens RL.
    J Immunol; 1989 Jun 15; 142(12):4307-13. PubMed ID: 2786027
    [Abstract] [Full Text] [Related]

  • 17. Cells isolated from bone-marrow and lungs of allergic BALB/C mice and cultured in the presence of IL-5 are respectively resistant and susceptible to apoptosis induced by dexamethasone.
    Maximiano ES, Elsas PX, de Mendonça Sales SC, Jones CP, Joseph D, Vargaftig BB, Gaspar Elsas MI.
    Int Immunopharmacol; 2005 May 15; 5(5):857-70. PubMed ID: 15778122
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of retroviral-mediated gene transfer into primary human stromal cells of Flt3-ligand, interleukin 3 and GM-CSF on production of cord blood progenitor cells in long-term culture.
    Balduini A, Braun SE, Cornetta K, Lyman S, Broxmeyer HE.
    Stem Cells; 1998 May 15; 16 Suppl 1():37-49. PubMed ID: 11012147
    [Abstract] [Full Text] [Related]

  • 19. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR.
    Stem Cells; 1997 May 15; 15(1):63-72. PubMed ID: 9007224
    [Abstract] [Full Text] [Related]

  • 20. Allergen stimulates bone marrow CD34(+) cells to release IL-5 in vitro; a mechanism involved in eosinophilic inflammation?
    Johansson AK, Sjöstrand M, Tomaki M, Samulesson AM, Lötvall J.
    Allergy; 2004 Oct 15; 59(10):1080-6. PubMed ID: 15355467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.